Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Sarcoma × Epirubicin × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Triple Negative Breast Neoplasms 10 Lymphoma, Large B-Cell, Diffuse 2 Resectable HER2-positive Breast Cancer 1 Pathologic Complete Response 1 Non-Muscle Invasive Bladder Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, T-Cell, Peripheral 1 Inflammatory Breast Neoplasms 1 HR+/HER2- Breast Cancer 1 Epstein-Barr Virus Infections 1 Congenital Abnormalities 1 Carcinoma, Adenoid Cystic 1 CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction 1

Interventions

Doxorubicin 21 pembrolizumab 19 Radiotherapy 16 Magnetic Resonance Spectroscopy 14 Nivolumab 13 Cyclophosphamide 13 Specimen Handling 12 Ifosfamide 10 Gemcitabine 10 Biopsy 10 Surgical Procedures, Operative 9 pazopanib 8 Ipilimumab 8 Blood Specimen Collection 8 X-Rays 7 Trabectedin 7 Temozolomide 7 Radiation 7 fludarabine 6 tazemetostat 5 olaparib 5 eribulin 5 cabozantinib 5 Standard of Care 5 Phantoms, Imaging 5 Irinotecan 5 talimogene laherparepvec 4 fludarabine phosphate 4 atezolizumab 4 abemaciclib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡